Feedback / Questions
Stalaris (efzofitimod) - aTyr Pharma, Kyorin
https://www.hcplive.com/view/efzofitimod-fails-to-meet-primary-end-point-in-phase-3-pulmonary-sarcoidosis-trial
Sep 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next